Orrin Ailloni-Charas

Orrin Ailloni-Charas
Orrin Ailloni-Charas
Name: Orrin Ailloni-Charas
Title: MD, MBA, Managing Partner
Company: Global Health Impact Fund
Biography:

Bio:

Dr. Orrin Ailloni-Charas is an honors graduate of the University of Pennsylvania, earned his MD at the NYU School of Medicine, and earned his MBA from Columbia University.  He completed his residency as a specialist in anesthesia at the Mount Sinai Hospital in New York City. He is a Board Certified Anesthesiologist and served from 2003-2016 as the Chief Financial Officer of a large private anesthesia practice in San Francisco. From 2016-2018, Dr. Ailloni-Charas was the Vice President of Clinical Investments at AngelMD, where he developed an evaluation platform and funding process for healthcare startups as well as built a large network of experts to support due diligence and investment. In 2018 until early 2020, he worked at RedCrow as Managing Director where he developed a comprehensive, qualitative and quantitative analytical platform for evaluating startups. He also produced and hosted a web-based show in partnership with NASDAQ which was focused on healthcare startups.    Prior to 2016, he held several consulting positions with digital health and biopharma companies, including with Pacira and HealthTap.

Dr. Ailloni-Charas is the CEO and Managing Partner of the Global Health Impact Fund(GHIF), a venture fund focused on  investing in early stage healthcare innovation. The GHIN is physician-led and physician-driven and leverages the expertise of large networks of physicians and domain experts with its proprietary, data science platform. The insights and experiences of the physician leaders, filter through the analytical engine provide the basis for improved investing outcomes by allowing for better understanding of the clinical and business challenges early stage healthcare startups encounter.

Dr. Ailloni-Charas draws on his experience of 25 years in the clinical practice of anesthesia at top medical institutions as well as lessons learned as an investment leader and physician network builder in the early and mid-stage healthcare vertical.